Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002)
Clinical trial NCT03859739 · COMPLETED
Trial details
- NCT number
- NCT03859739
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2020-05-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.